« Return to News | CROs/Service Providers

BioReliance opens U.S. clearance services laboratories

Monday, September 9, 2013 12:08 PM

Sigma-Aldrich BioReliance, the biologics and early-development services business under SAFC, has opened a new clearance services facility in Rockville, Md.

This facility allows BioReliance to offer increased capacity and flexible scheduling. The new U.S. facility more than doubles the space available to clients to conduct their critical downstream bioprocessing studies.

The Rockville facility features four large clearance suites with modular layouts that allow for customized laboratory setups. All studies performed at the facility are completely secure and supported by dedicated scientists and state-of-the-art chromatography equipment, such as GE Healthcare's ÄKTA avant. Every project is fully compliant with applicable global guidelines and regulations. Completed studies receive a consolidated report that includes comprehensive titration and/or process data. BioReliance has already successfully conducted several client studies and quality audits in the new facility.

Clients using BioReliance's U.S. facility will have access to personalized modular laboratory suites with technology-enabled lounges, "suite-to-lounge" monitoring and support from facility personnel.

The Rockville Clearance Services facility investment completes BioReliance's upgrade. The Scotland Clearance Services laboratories were renovated and expanded in 2011.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.